Boehringer Ingelheim has joined the surge of companies entering the B-cell depletion space. But while its peers have largely ...

The U.S. Food and Drug Administration has granted regenerative medicine advanced therapy (RMAT) designation to Fate's FT819 ...

Researchers who discovered a mechanism that prevents B cells from attacking the body’s own tissues in autoimmune diseases win ...

known as Atypical B cells (ABCs), to fight infectious diseases such as malaria. The scientists say ABCs ... Discovery May Enable an Effective Long-Term Lupus Treatment Feb. 6, 2024 — Researchers ...

The Lupus Foundation of America (LFA) is excited to share that enrollment for the MiSLE (Mesenchymal Stromal Cells in ...

Zenas BioPharma, Inc.'s obexelimab's potential in treating autoimmune diseases and upcoming phase 2 & 3 trial results. Read ...

The Lupus Research Alliance (LRA) is proud to announce the recipients of this year’s Lupus Innovation Award (LIA), addressing many critical themes in lupus research including novel therapeutic ...